Statements (32)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
antidote chelating agent |
| gptkbp:administeredBy |
intramuscular injection
|
| gptkbp:ATCCode |
V03AB03
|
| gptkbp:CASNumber |
59-52-9
|
| gptkbp:chemicalFormula |
C3H8O2S2
|
| gptkbp:developedBy |
gptkb:United_Kingdom
gptkb:World_War_II |
| gptkbp:discoveredBy |
1940
|
| gptkbp:firstUsedAs |
antidote to chemical warfare agents
|
| https://www.w3.org/2000/01/rdf-schema#label |
British Anti-Lewisite
|
| gptkbp:includedIn |
gptkb:World_Health_Organization's_List_of_Essential_Medicines
|
| gptkbp:meltingPoint |
62 °C
|
| gptkbp:molecularWeight |
124.23 g/mol
|
| gptkbp:nameOrigin |
antidote to lewisite
|
| gptkbp:otherName |
gptkb:dimercaprol
|
| gptkbp:sideEffect |
nausea
vomiting hypertension tachycardia pain at injection site |
| gptkbp:solubility |
insoluble in water
soluble in alcohol |
| gptkbp:usedFor |
treatment of antimony poisoning
treatment of arsenic poisoning treatment of gold poisoning treatment of lead poisoning treatment of lewisite poisoning treatment of mercury poisoning |
| gptkbp:bfsParent |
gptkb:BAL
|
| gptkbp:bfsLayer |
6
|